Show simple item record

dc.contributor.authorAbolhasani, H
dc.contributor.authorZarghi, A
dc.contributor.authorAbolhasani, A
dc.contributor.authorHamzeh-Mivehroud, M
dc.contributor.authorBargahi, N
dc.contributor.authorNotash, B
dc.contributor.authorMojarrad, JS
dc.contributor.authorDastmalchi, S
dc.date.accessioned2018-08-26T08:51:28Z
dc.date.available2018-08-26T08:51:28Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53406
dc.description.abstractA new series of 3',4'-bis(3,4,5-trimethoxyphenyl)-4'H-spiro[indene-2,5'-isoxazol]-1(3H)-one derivatives was designed and synthesized. The cytotoxic effects of the synthesized compounds were evaluated on several different human cancer cells. Among them, compound 9e displayed the most potent in vitro antiproliferative activity with IC50 values of 0.07آ±0.01 ?M on T47D cells. Another potent derivative 9h displayed an IC50 value of 0.12آ±0.07 ?M against T47D cells, comparable to that of the positive controls (Colchicine' Cisplatin' Vincristine' Vinblastine' Doxorubicin' Celecoxib). The structure-activity relationships were discussed and both anti-tubulin and COX-2 inhibitory effects were proposed for the developed compounds é 2015 Bentham Science Publishers.
dc.language.isoEnglish
dc.relation.ispartofLetters in Drug Design and Discovery
dc.subject2 (3,4,5 trimethoxybenzylidene) 2,3 dihydro 1h inden 1 one
dc.subject2 (4 (methylsulfonyl)benzylidene) 2,3 dihydro 1h inden 1 one
dc.subject2 (4 methoxybenzylidene) 2,3 dihydro 1h inden 1 one
dc.subject2 benzylidene 2,3 dihydro 1h inden 1 one
dc.subject3' (3,4 dimethoxyphenyl) 4' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject3' (3,4 dimethoxyphenyl) 4' (4 (methylsulfonyl)phenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject3' (4 methoxyphenyl) 4' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject3' phenyl 4' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5 isoxazol] 1(3h) one
dc.subject3',4' bis(3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject3,4 dimethoxybenzaldehyde oxime) (3,4 dimethoxy benzaldoxime) (veratraldehyde oxime)
dc.subject3,4,5 trimethoxybenzaldehyde oxime (3,4,5 trimethoxy benzaldoxime)
dc.subject4 methoxybenzaldehyde oxime) (4 methoxy benzaldoxime)
dc.subject4' (4 (methylsulfonyl)phenyl) 3' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject4' (4 methoxyphenyl) 3' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subject4' phenyl 3' (3,4,5 trimethoxyphenyl) 4'h spiro[indene 2,5' isoxazol] 1(3h) one
dc.subjectantineoplastic agent
dc.subjectbenzaldehyde oxime (benzaldoxime)
dc.subjectcelecoxib
dc.subjectcisplatin
dc.subjectcolchicine
dc.subjectcyclooxygenase 2 inhibitor
dc.subjectdoxorubicin
dc.subjectisoxazole derivative
dc.subjectunclassified drug
dc.subjectvinblastine
dc.subjectvincristine
dc.subjectantineoplastic activity
dc.subjectantiproliferative activity
dc.subjectArticle
dc.subjectcancer cell
dc.subjectcontrolled study
dc.subjectdrug design
dc.subjectdrug potency
dc.subjectdrug screening
dc.subjectdrug synthesis
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.subjectin vitro study
dc.subjectpriority journal
dc.subjectstructure activity relation
dc.titleDesign, synthesis and in vitro cytotoxicity evaluation of new 3',4'-bis (3,4,5-trisubstituted)-4'H-spiro[indene-2,5'-isoxazol]-1(3H)-one derivatives as promising anticancer agents
dc.typeArticle
dc.citation.volume11
dc.citation.issue10
dc.citation.spage1149
dc.citation.epage1161
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.2174/1570180811666140704172442


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record